Physician profile
Jennifer Johnson
NPI 1710006382
$854.12
in general payments reported to CMS, 2019-2025
10 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $116 · 2021: $89.92 · 2022: $38.00 · 2023: $93.05 · 2024: $80.21 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $558.00 | 2019-2025 | Evenity, Prolia, Prolia |
| Novo Nordisk INC | $112.30 | 2023-2025 | Wegovy |
| Abbvie INC. | $41.90 | 2021 | |
| Lilly USA, LLC | $40.54 | 2019-2022 | |
| Cleerly, INC. | $27.13 | 2025 | Cleerly Labs, Cleerly Ischemia |
| United Therapeutics Corporation | $17.71 | 2019 | |
| Glaxosmithkline, LLC. | $16.74 | 2023 | Shingrix, Arexvy |
| Edwards Lifesciences Corporation | $16.01 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $14.87 | 2021 | |
| Qol Medical, LLC | $8.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.